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        Sialic acids are a diverse family of acidic sugars 
with a shared nine-carbon backbone. They par-
ticipate in numerous cell –  cell recognition events 
and can also mediate the binding to vertebrate 
cells of certain toxins and viruses (  1, 2  ). A rela-
tively common postsynthetic modifi  cation  of 
sialic acid is   O  -acetylation at the C-9 position. 
Acetylation of sialic acid also frequently occurs 
at the C-7 position, from where the acetyl 
group can spontaneously migrate to the 9-OH 
position under physiological conditions. The 
hemagglutinin esterases of infl  uenza C viruses 
and certain nidoviruses, including group 2 coro-
naviruses, recognize 9  -O-  acetylated sialic acid  –
  containing glycoconjugates on the surface of 
host cells, and some can remove the 9-  O  -acetyl 
moieties (  3, 4  ). However, the in vivo biological 
function of this acetylation event has remained 
a mystery. One attempt to elucidate the biolog-
ical role of sialic acid 9-  O  -acetylation involved 
the transgenic expression of Infl  uenza C hem-
agglutinin esterase in mice (  5  ). This led to a de-
fect in early embryogenesis, indirectly suggesting 
that 9-  O  -acetyl sialic acid may be essential dur-
ing murine development. In vitro studies (  6  ) 
suggested that 9-  O  -acetylation of     2  –  6-linked 
sialic acid containing glycoconjugates impairs 
the recognition of this glycan moiety by certain 
Siglecs (sialic acid binding Ig superfamily lec-
tins) including CD22. However, despite these 
and other tantalizing clues, the intrinsic in vivo 
functions of this abundant modifi  cation  have 
not been established. 
  The Siglecs are the largest known group of 
vertebrate sialic acid-recognizing cell surface 
proteins. This family comprises 13 members 
in humans including sialoadhesin (Siglec-1), 
CD22 (Siglec-2), CD33 (Siglec-3), myelin as-
sociated glycoprotein (Siglec-4), Siglec-15, and 
the so-called CD33-related Siglecs, 5  –  10, 11, 
and 14 (  7  –  9  ). CD22 is one of the best studied 
Siglecs and binds specifi  cally to     2  –  6-linked 
sialic acid  –  containing N-glycans (  10, 11  ). 
CD22 inhibitory signaling depends on the re-
cruitment of SHP-1 to phosphorylated tyrosine 
residues in immunoreceptor tyrosine-based in-
hibitory motifs (ITIM) in its cytoplasmic tail (  12  ). 
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  We show that the enzymatic acetylation and deacetylation of a cell surface carbohydrate 
controls B cell development, signaling, and immunological tolerance. Mice with a mutation 
in sialate:  O  -acetyl esterase, an enzyme that specifi  cally removes acetyl moieties from the 
9-OH position of     2  –  6-linked sialic acid, exhibit enhanced B cell receptor (BCR) activa-
tion, defects in peripheral B cell development, and spontaneously develop antichromatin 
autoantibodies and glomerular immune complex deposits. The 9-  O  -acetylation state of 
sialic acid regulates the function of CD22, a Siglec that functions in vivo as an inhibitor of 
BCR signaling. These results describe a novel catalytic regulator of B cell signaling and 
underscore the crucial role of inhibitory signaling in the maintenance of immunological 
tolerance in the B lineage. 
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  Generation of   Siae        2/    2   mice 
  Exon 2 of the   Siae   gene is unique to   Lse  . An engineered in-
frame deletion of exon 2 in a murine   Lse   complementary DNA 
resulted in a protein that lacked esterase activity (  Fig. 1 A  ).   
Genomic deletion of exon 2 was achieved as described in the 
Materials and methods (  Fig. 1 B  ). After germline transmis-
sion, homozygous mutant mice were generated and were found 
to be viable. Truncated exon 2  –  defi  cient   Siae   mRNA could 
be detected in KO mice (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20081399/DC1). Cytosolic 
esterase mRNA continues to be transcribed in these mutant 
mice. We refer to these KO animals as   Siae        2/    2   mice. 
  Enhanced B lymphocyte antigen receptor signaling 
in   Siae        2/    2   mice 
  Because Siae has the potential to remove 9-  O  -acetyl residues 
from     2  –  6-linked sialic acid containing Siglec ligands, we pre-
dicted that B cells from mice lacking this esterase might exhibit 
enhanced BCR signaling similar to that noted in CD22-null 
mice (  13  –  16  ). Mice were fi  rst bred into the C57BL/6 back-
ground for 10 generations. B cells from WT and   Siae        2/    2   mice 
were gated on, and the accumulation of cytoplasmic calcium 
after ligation of the BCR was analyzed using fl  ow cytometry. 
As seen in   Fig. 2  , BCR cross-linking resulted in an accelerated 
and enhanced calcium fl  ux.   A similar result was seen when 
purifi  ed splenic B cells from mutant and WT mice were ana-
lyzed (Fig. S4, available at http://www.jem.org/cgi/content/
full/jem.20081399/DC1). These data suggested that in the ab-
sence of functional Siae, BCR signal strength is markedly en-
hanced and that this alteration in signal strength is an intrinsic 
property of mutant B lymphocytes. 
  Defective CD22 signaling and hyperacetylation of     2  –  6-
linked sialic acid moieties on   Siae   mutant B cells 
  The defect in Siae could result in the increased acetylation of 
    2  –  6-linked sialic acid on   N  -glycans in B cells and, thus, at-
tenuate the ability of glycoproteins on B cells to ligate CD22 
and generate inhibitory signals. We sought to examine if 
there was a defect in CD22 signaling in   Siae        2/    2   mice. After 
BCR cross-linking, CD22 was isolated by immunoprecipita-
tion, and immunoprecipitates were examined for CD22 tyro-
sine phosphorylation and for associated SHP-1 using Western 
blot assays. As seen in   Fig. 3   (left, experiment 1; and right, 
experiment 2), tyrosine phosphorylation of CD22 after BCR 
signaling was reduced in   Siae        2/    2   mice in spite of similar lev-
els of surface CD22 expression in WT and mutant mice (Figs. 
S5 and S6, available at http://www.jem.org/cgi/content/
full/jem.20081399/DC1).   Recruitment of SHP-1 by CD22 
was clearly impaired after BCR ligation of   Siae        2/    2   B cells as 
compared with WT B cells. This result showing diminished 
SHP-1 recruitment in   Siae        2/    2   B cells is consistent with the 
accelerated enhancement in BCR signal strength observed in 
  Siae        2/    2   mice. 
  It remained to be demonstrated whether a defect in Siae 
would result in enhanced 9-  O-  acetylation of     2  –  6-linked si-
alic acid in   Siae        2/    2   mice. 9-  O  -acetylation of sialic acid has not 
Antigen receptor cross-linking leads to the activation of 
Lyn and other less abundant Src-family kinases that phos-
phorylate ITIM tyrosines in CD22. Initiation of inhibitory 
signaling by CD22 is not well understood and the exact 
mechanism remains controversial. The simplest model that 
may be indirectly inferred from the phenotypes of KO mice 
(  13  –  20  ) suggests that antigen receptor ligation contributes to 
the sialic acid  –  dependent recruitment of CD22 to the BCR 
and the subsequent phosphorylation by Lyn of CD22 ITIM 
tyrosines, which is followed by the recruitment and activa-
tion of SHP-1. Other mechanisms of signal initiation have 
been suggested by several studies variously implicating sialic 
acid  –  dependent homooligomerization and sialic acid  –  inde-
pendent association of this Siglec with the B cell receptor 
(BCR) (  21  –  24  ). Because CD22 is expressed constitutively 
on mature B cells and     2  –  6-linked sialic acid  –  containing 
  N  -glycans are abundantly present on the cell surface, it could 
be argued that CD22 inhibition may itself be constitutive. 
How inhibitory signaling via CD22 is temporally regulated 
in mature B cells is unclear. Because CD22 does not bind to 
9-  O  -acetylated sialic acid in vitro (  6  ), we considered the 
possibility that the function of this Siglec might be regu-
lated in vivo by the enzymatic acetylation and deacetylation 
of     2  –  6-linked sialic acid. Sialic acid acetyl esterase (Siae), 
which is molecularly characterized as an enzyme that re-
moves acetyl groups from the 9-OH position of     2  –  6-linked 
sialic acid (  25  ), was also independently identifi  ed as a gene 
that is up-regulated during B cell maturation (  26  ), suggest-
ing a role in the biology of B lymphocytes. In this paper, we 
show that Siae infl  uences B cell signaling and B cell devel-
opment and participates in inhibitory signaling mechanisms 
that are crucial to the maintenance of immunological toler-
ance in the B lineage. 
    RESULTS   
  Sialate   O  -acetylesterase is secreted and can access 
the cell surface 
  The   Siae   gene (  sialate:O-acetyl esterase  ) can generate two alter-
natively spliced variants. One form contains a signal peptide 
and can encode a protein that enters the secretory pathway 
(originally called Lse [lysosomal sialic acid acetylesterase]), 
whereas the other lacks this signal peptide and encodes a 
cytosolic esterase (  25  –  27  ). Although the Lse protein was 
thought to localize to lysosomes, a site that would not be 
suitable for the modifi  cation of Siglec ligands, we have ob-
served in transfected cells that this protein exhibits, at best, a 
limited lysosomal localization and is secreted and can bind to 
the surface of transfected cells (Figs. S1 and S2, available at 
http://www.jem.org/cgi/content/full/jem.20081399/DC1). 
The enzyme, therefore, has the potential to remove acetyl 
groups from 9-  O  -acetylated Siglec ligands in a post Golgi 
vesicle or at the cell surface. Although some antibodies against 
Siae have been generated, they lack the specifi  city to detect 
Siae in murine cells and tissue sections. The actual location 
of the Siae protein in murine B cells is therefore yet to be 
conclusively established. JEM VOL. 206, January 19, 2009 
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    Figure 1.         Targeted deletion of exon 2 of murine   Siae   results in enhanced BCR signaling.   (A) Deletion of exon 2 abrogates the esterase activity of 
the Lse form of Siae. A WT C-terminal FLAG-tagged murine   Siae   expression construct of the   Lse   form and an exon 2  –  deleted version of this complemen-
tary DNA were transfected into COS7 cells. Cell culture medium was recovered and the recombinant protein purifi  ed by an antibody column directed to 
the FLAG epitope. Western blotting analysis on eluate fractions showed that both proteins were expressed, bound, and eluted from the column. Column 
eluate fractions were subjected to an assay for sialic acid 9-  O  -acetylesterase activity (left) and acetyl-CoA esterase activity (right) as previously described 
(  25  ). Y axes show cpm. (B) Targeting strategy for the deletion of exon 2 of murine Siae. The top shows the targeting construct used to specifi  cally target 
exon 2 of   Siae  . The middle shows the expected structure of the locus after targeting. The bottom left shows Southern Blotting of embryonic stem (ES) 
cells at each step of manipulation detected by a loxP-specifi  c probe. The black line indicates that intervening lanes have been spliced out. The bottom 
right shows Southern blotting of mouse tail DNA after mating heterozygous mice that also expressed the ZP3-Cre Transgene. The expected deleted frag-
ment is 6.5 kb and the expected WT fragment is 4.2 kb.     128 CELL SURFACE ACETYLATION AND B CELL FUNCTION   | Cariappa et al. 
uptake studies uncovered a delayed stimulus strength  –  depen-
dent inhibition of proliferation (Fig. S8) that might be related 
to a modest increase in ongoing spontaneous apoptosis of fol-
licular B cells in mutant mice (Fig. S9). Four diff  erent CD22-
null mutant mice have been described by diff  erent groups 
(  13  –  16  ), and although enhanced antigen receptor signaling 
was observed in all four mutants, BCR-induced proliferation 
was enhanced in some mutants and diminished in others. En-
hanced cell death has also been reported in some CD22 mu-
tants (  14, 16  ). 
  Siae infl  uences peripheral B cell development 
  Enhanced BCR signaling in the absence of negative regula-
tors of the BCR such as Aiolos or CD22 has been linked to 
the relative absence of marginal zone (MZ) B cells (  29  –  31  ). 
As seen in   Fig. 5 A  , immunohistochemistry revealed a marked 
reduction in splenic MZ B cells in   Siae        2/    2   mice, although 
been previously observed on B cells, and it is likely that this 
modifi  cation occurs only transiently on WT B lymphocytes. A 
well established reagent for the detection of 9-  O-  acetylated 
    2  –  6-linked sialic acid is a fusion protein containing the Fc 
portion of human IgG and the infl  uenza C hemagglutinin es-
terase treated with diisopropyl fl  uorophosphate (  28  ). Modifi  -
cation of the catalytic serine nucleophile in this fusion protein 
by diisopropyl fl  uorophosphate permits the viral protein to 
bind to 9-  O  -acetyl sialic acid but not to cleave it. This reagent, 
designated CHE-FcD, binds to   N  -linked glycans that are dec-
orated with 9-  O  -acetylated     2  –  6-linked sialic acid moieties. 
As predicted, a consistent increase in 9-  O  -acetylation was de-
tected in   Siae        2/    2   B cells compared with WT B cells (  Fig. 4  ).   
  In keeping with the increased magnitude of BCR signal-
ing, antigen receptor ligation induced enhanced proliferation 
of B cells in   Siae        2/    2   mice (Fig. S7, available at http://www
.jem.org/cgi/content/full/jem.20081399/DC1). Thymidine 
    Figure 2.         Accelerated and enhanced BCR signaling in Siae mutant mice.   Splenocytes from mutant and WT mice were loaded with Indo-1, reacted 
with 2.4G2, an Fc     III/II receptor-blocking antibody, stained with follicular and MZ B cell phenotype markers, and stimulated with F(ab   ) 2   anti-IgM.  Popu-
lations gated on include newly formed (NF/T1), follicular (FO), and MZ B cells and their precursors (MZ and MZP). Results are representative of three sepa-
rate experiments and a total of six mice.     JEM VOL. 206, January 19, 2009 
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are consistent with the ability of Siae to negatively regulate 
BCR signaling. 
  Follicular B cells occupy two niches: the follicular niche 
in conventional secondary lymphoid organs and the peri-
sinusoidal niche in the BM (  32, 33  ). In mutant mice, includ-
ing   Aiolos      /        mice,   CD22      /        mice, and   CD72      /        mice, 
all of which exhibit enhanced BCR signal strength, there is 
some reduction in follicle size was also apparent.   Flow cyto-
metric analysis revealed that IgM  hi  IgD  hi   CD21  hi   MZ B cell 
precursors (MZP), as well as IgM  hi  IgD  lo  CD21  hi   MZ B cells, 
were markedly reduced in   Siae        2/    2   mice (  Fig. 5 B  ). An analy-
sis of the absolute numbers of B cells in   Siae        2/    2   mice (  Table I  ) 
revealed a striking decrease in MZP and MZ B cells and a 
more modest reduction in follicular B cells.   These results 
    Figure 3.         Defective CD22 signaling in   Siae      2/    2     mice.   Decreased recruitment of SHP-1 by CD22 in Siae mutant mice. Splenocytes from mutant and 
WT mice were stimulated via the BCR and immunoprecipitated with antibody to CD22, and Western blots were developed with antibodies to SHP-1, 
CD22, and phosphotyrosine. Results of two experiments are shown on the top left and the top right. The bottom presents SHP-1/CD22 ratios quantitated 
by  densitometry.   
    Figure 4.         Increased 9-  O  -acetylation of     2  –  6-linked sialic acid in Siae mutant B cells.   Splenocytes from 11-wk-old WT and mutant mice were 
treated with the CHE-FcD reagent and stained with surface phenotype markers. Results are representative of three mice. X axes show log of fl  uores-
cence intensity.   130 CELL SURFACE ACETYLATION AND B CELL FUNCTION   | Cariappa et al. 
    Figure 5.         The   Siae   mutation affects the development of MZ and perisinusoidal B cells in a cell-intrinsic manner.   (A)  Immunohistochemistry 
reveals a decrease in MZ B cells in   Siae     2/  2   spleens. B cells were stained with anti-IgM (brown) and metallophilic macrophages with the MOMA-1 JEM VOL. 206, January 19, 2009 
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sion and an increase in 9-  O  -acetylation of Neu5Ac (  43  ). 
  Cmah  -null mice as well as   Cmah/Siae   double mutant mice 
would therefore be expected to exhibit BCR hyperreac-
tivity, the relative loss of MZ B cells, and a relative loss of 
perisinusoidal B cells. Indeed, B cells from   Cmah   mutant 
mice have been reported to exhibit an enhanced prolifera-
tive response to BCR cross-linking (  44  ). We show here that 
B cells from   Cmah  -null mice have higher levels of 9-  O  -
acetyated sialic acid as revealed by CHE-FcD binding (Fig. 
S10, available at http://www.jem.org/cgi/content/full/jem
.20081399/DC1). Both   Cmah  -null mice and   Cmah/Siae   
double mutant mice present with enhanced BCR activation 
as measured by the release of intracellular calcium after anti-
gen receptor ligation and, as predicted, present with marked 
reductions in MZ B cells and perisinusoidal B cells (Figs. S10 
and S11). A combination of two changes in the structure of 
sialic acid that each compromise CD22 binding results in a 
phenotype that is similar to that seen in mice with enhanced 
9-  O  -acetylation of sialic acid alone but is quite distinct from 
the phenotype of mice with the complete loss of     2  –  6-linked 
sialic acid. 
  Siae mutant mice exhibit spontaneous increases in class-
switched immunoglobulins and autoantibodies 
  Many phenotypic features of   Siae        2/    2   mice resemble those 
seen in the absence of CD22. These include enhanced BCR 
signaling, the loss of MZ B cells, and a reduction in perisinu-
soidal B cells. Subtle alterations in responses to synthetic 
T-dependent and T-independent antigens have been described 
in CD22-null mice, and an altered spectrum of responsiveness 
to similar antigens was also noted in   Siae        2/    2   mice. Immuni-
zation with DNP-KLH resulted in diminished IgG2a, IgG2b, 
and IgG3 responses in   Siae   mutant mice (Fig. S12, available at 
http://www.jem.org/cgi/content/full/jem.20081399/DC1). 
  Siae        2/    2   mice spontaneously developed high levels of certain 
class-switched serum immunoglobulins, including IgE and 
IgG  2b   (  Fig. 6 A  ), as well as high titers of antinuclear antibodies 
and circulating immune complexes as early as at 20 wk of 
age (  Fig. 6 B  ).   These mice also develop an immune complex 
glomerulonephritis (  Fig. 6, C and D  ). Anti-DNA antibodies 
develop in CD22-null mice after 9 mo of age, but glomerular 
immune complex deposits were not observed in these mice 
on a C57BL/6 background (  45  ). 
a selective loss of recirculating follicular phenotype B cells 
from the perisinusoidal niche even as these cells effi   ciently 
seed the follicular niche (  14  –  16, 34, 35  ). We examined fol-
licular phenotype B cell populations in the perisinusoidal 
niche in   Siae        2/    2   mice and noted a marked and selective loss 
of recirculating B cells in the BM (  Fig. 5 C   and   Table II  , frac-
tion F), again paralleling a phenotypic alteration previously 
noted in CD22-null mice (  14  –  16  ).   We analyzed peritoneal 
B-1 B cell populations in   Siae        2/    2   and WT mice and noted 
an increase in IgM  hi   CD43  +   CD5        B1b B cells but decreased 
numbers of IgM  hi   CD5  +   B1a B cells in   Siae        2/    2   mice (  Fig. 5 D  ). 
The CD22 mutants showed increased B1 cells (  13  ), increased 
B1a cells (  15  ), or normal numbers (  16  ). 
  A lymphocyte-intrinsic defect in Siae contributes 
to peripheral B cell phenotypes 
  To determine whether the alteration in peripheral B cell 
populations refl  ected a cell-intrinsic defect in Siae function, 
we reconstituted   Rag-1      /        mice with hematopoietic stem 
cells from WT and   Siae        2/    2   BM.   Siae        2/    2   lymphocytes in 
reconstituted mice exhibited a defect in MZ B cell develop-
ment and a reduction of perisinusoidal BM B cells (  Fig. 5 E  ), 
which establishes that these developmental abnormalities 
represent lymphocyte-intrinsic defects. No gross defect in 
T cell development was discovered in the absence of Siae 
(  Fig. 5 F  ), although there was a small decrease in T cell num-
bers both in the thymus and the spleen (  Tables III and IV  ).   
Other B cell  –  defi  cient mice have been reported to have a 
mild decrease in T cell numbers (  36  ). The phenotype of   Siae   
mutant mice in which a subtle alteration may have been gen-
erated in CD22 ligands is very diff  erent from that of the 
  ST6GalI  -null mouse, which completely lacks     2  –  6-linked 
sialic acid and which presents with defects in B cell activation 
and in thymocyte development (  37, 38  ). Murine CD22, un-
like human CD22, has a markedly higher affi   nity for Neu5Gc 
(sialic acid with an   N  -glycolyl moiety in the C5 position; the 
major form in the mouse) as compared with Neu5Ac (sialic 
acid with an   N  -acetyl moiety in the C5 position) (  39  –  42  ). 
The enzyme CMP-Neu-5Ac hydroxylase (CMAH) converts 
CMP-Neu5Ac to CMP-Neu5Gc, and mice lacking this 
enzyme not only synthesize   N  -glycans with a subtly diff  er-
ent form of sialic acid that binds CD22 poorly but they also 
exhibit a poorly understood down-regulation of   Siae   expres-
antibody (blue). FO, follicular compartment, and MZMM, MZ metallophilic macrophages. Results are representative of three mice per group in the age 
range of 8  –  12 wk. Bars, 100   μ  m. (B) Flow cytometric analyses reveal a reduction in MZ B cells in   Siae     2/  2   mice. Splenic B cell populations were analyzed 
by fl  ow cytometry in mutant and WT mice. MZ, MZ B cells, NF, newly formed B cells; FO-I, follicular type I B cells and FO-II, follicular type II B cells (  61  ). 
Results are representative of   >  10 mice per group. (C) Perisinusoidal BM B cells are reduced in   Siae     2/  2   mice as demonstrated by fl  ow cytometry. BM B cell 
populations were analyzed by fl  ow cytometry. Fractions (Fr.) A  –  C  ’   represent pro  –  B and large pre  –  B cells, Fraction D represents small pre  –  B cells, Fraction E 
represents immature B cells, and Fraction F represents recirculating perisinusoidal B cells. The gating strategy was described previously  ( 32 ).  Results  are 
representative of fi  ve mice per group. (D) Peritoneal B-1b B cells are increased in   Siae     2/  2   mice but B-1a B cells are decreased. Flow cytometric analyses 
were performed on peritoneal cavity B cells. Results are representative of fi  ve mice per group. The histogram shows absolute numbers of peritoneal B1 
cells in WT and   Siae     2/  2   mice with three mice per group. Error bars represent SEM. (E) Siae affects B cell development in a B cell  –  intrinsic manner. 
  Rag-1     /     mice were reconstituted with mutant or WT BM. Spleen and BM B cells were analyzed 7 wk later in the reconstituted mice. Results are repre-
sentative of three mice per group. (F) Normal T cell development in the thymus and spleen in   Siae     2/  2   mice. Thymocyte and splenic populations were 
analyzed by fl  ow cytometry in WT and   Siae     2/  2   mice. Results are representative of three mice per group.     
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dal B cells, alterations in B cell proliferation that are depen-
dent on the degree and duration of BCR cross-linking, some 
increase in follicular B cell apoptosis, and the spontaneous 
development of antinuclear antibodies. 
  Our results suggest that in   Siae   mutant mice, terminal 
    2  –  6-linked sialic acid moieties on   N  -linked glycans are 
9-  O  -acetylated and, as a result, CD22 cannot readily inhibit 
BCR signaling. Although these results imply that ligation of 
CD22 by     2  –  6 sialic acid  –  containing ligands contributes to 
inhibitory signaling, the precise role that sialoglyconjugates 
play in the function of CD22 remains to be determined with 
certainty. The phenotypes of CD22 KO mice clearly suggest 
that a major in vivo function of this Siglec is to attenuate 
BCR signaling, but other studies have suggested that CD22 
may potentially contribute to both inhibitory and activating 
functions (  47  ). Mutating or blocking the sialic acid bind-
ing site of CD22 in a cell line context led to a loss of CD22 
  It has been suggested that CD22 may function as an en-
forcer of peripheral tolerance (  45  ), and a possible role for 
CD22 in setting signaling thresholds in the context of toler-
ance has been previously postulated (  46  ). Lyn-null mice 
(  17  –  19  ), as well as conditional SHP-1 mice (  21  ), develop a 
lupuslike phenotype, supporting the notion that CD22, pos-
sibly other Siglecs, SHP-1, and Lyn are part of an inhibitory 
axis setting higher thresholds for B cell activation by self-an-
tigens as well as by exogenous antigens (  46  ). Siae may be an 
important component of this inhibitory axis (  Fig. 7  ).   
    DISCUSSION   
  In this article, we show that mice with an engineered deletion 
in   Siae   phenocopy many of the alterations seen in CD22 -null 
mice (  13  –  16  ). These common features include an enhance-
ment of BCR-induced release of calcium from internal 
stores, the loss of MZ B cells, a reduction in BM perisinusoi-
    Table I.        Absolute numbers of B cells in spleen 
Fraction C57BL/6*   Siae        2/    2  * Decrease (fold)
MZ 4.6 (0.9) 0.2 (0.1) 23.0
NF 2.9 (0.1) 1.8 (0.1) 1.6
MZP 2.1 (0.1) 0.2 (0.1) 10.5
FO 18.5 (1.5) 3.6 (1.1) 5.1
Total cell count 73.0 (3.8) 30.0 (6.3) 2.4
The various B cell populations (MZ, MZP, NF, FO, and Fractions A  –  F) are defi  ned in the   Fig. 5   legend. *, mean (SD)   ×   10  6 ;   n   = 3 mice per group.
    Table II.        Absolute numbers of B cells in BM 
Fraction C57BL/6   Siae        2/    2  Decrease (fold)
A  –  C  ’  0.7 (0.1) 0.7 (0.3) -
D  –  F 2.4 (0.1) 2.5 (1.2) -
D 0.95 (0.1) 1.7 (1.0) -
E 0.2 (0.0) 0.3 (0.1) -
F 0.9 (0.1) 0.2 (0.1) 4.5
Total cell count 15.4 (3.7)* 16.9 (2.8)* -
*, mean (SD)   ×   10  6 ;   n   = 3 mice per group.
    Table III.        Absolute numbers of T cells in thymus 
Fraction C57BL/6   Siae        2/    2  Decrease (fold)
CD4 1.9 (0.0) 1.6 (0.2) 1.18
CD8 0.8 (0.0) 1.5 (0.1) -
Total cell count 39.5 (0.7)* 36.6 (1.5)* 1.07
*, mean (SD)   ×   10  6 ;   n   = 3 mice per group.
    Table IV.        Absolute numbers of T cells in spleen 
Fraction C57BL/6   Siae        2/    2  Decrease (fold)
CD4 11.8 (0.2) 6.5 (0.6) 1.8
CD8 11.4 (1.2) 7.9 (0.2) 1.4
*, mean (SD)   ×   10  6 ;   n   = 3 mice per group.JEM VOL. 206, January 19, 2009 
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    Figure 6.         Increased serum immunoglobulins and autoantibodies in Siae mutant mice.   (A) Serum immunoglobulins of specifi  c isotypes are in-
creased in mutant mice. Immunoglobulin isotypes were quantitated by ELISA. Each data point represents a single mouse. Horizontal bars represent the 
mean. (B) Increased levels of autoantibodies in the serum of   Siae     2/  2   mice. ELISA was used to estimate the levels of various autoimmune antibodies in 
serum. Each data point represents one mouse. Horizontal bars represent the mean. Ages of mice in A and B ranged from 20  –  60 wk. The results presented 
A and B and in C and D are all from the same set of mice. (C) Siae mutant mice show histological features of glomerulonephritis. Paraffi  n-embedded sec-
tions of kidney from mutant and WT mice were stained with hematoxylin and eosin (top) and with periodic acid Schiff (PAS) reagent (bottom). The glom-
eruli of the mutant mice (top right) show mesangial hypercellularity and expansion caused by periodic acid Schiff  –  positive deposits (bottom). The 
magnifi  cation is marked on each image. Bars, 100   μ  m. Results are representative of mice described in A and B. (D) IgG immune complex deposition in 
glomeruli of   Siae     2/  2   mice.  Immunofl  uorescence studies on frozen sections of kidney reveal enlarged glomeruli with IgG-positive deposits in the mesan-
gium in   Siae     2/  2   mice. The magnifi  cation is marked on each image. Bars, 100   μ  m. These sections are from the same mice as those shown in C.     134 CELL SURFACE ACETYLATION AND B CELL FUNCTION   | Cariappa et al. 
    Figure 7.         Siae regulates the availability of Siglec ligands on B cells 
and thus controls B cell antigen receptor signal strength.   In  mature 
B cells, BCR signaling thresholds are set by inhibitory molecules such as 
CD22. Sialic acid  –  containing ligands for Siglecs can be   O  -acetylated by an 
  O  -acetyltransferase in the Golgi. Acetyl moieties may be subsequently 
removed by Siae in an exocytic compartment or on the cell surface. In the 
absence of functional Siae, BCR signaling is no longer constrained by 
CD22 or other Siglecs on B cells.     
inhibitory signaling as indicated by an enhanced calcium fl  ux 
after BCR ligation (  11, 48  ). Knockin mice harboring an iden-
tical mutation in the sialic acid binding site of CD22 exhib-
ited some, but not all, of the phenotypic changes seen in 
CD22 null mice. Strikingly, an enhanced calcium fl  ux was 
not observed in this knockin mouse after BCR ligation (  22  ). 
Background-dependent modifi  er genes do contribute to dif-
ferences seen in CD22-dependent phenotypes in KO and 
knockin animals, and there is growing evidence from SNP 
genotyping that even inbred mice strains are heterogenous at 
several loci (  49  ). Nevertheless, no satisfactory explanation can 
be provided at present for the discrepant results of site di-
rected mutagenesis-based studies of CD22 function. 
  ST6GalI is the sialyl transferase that transfers sialic acid in 
an     2  –  6-linked form from CMP-Sia to the preterminal ga-
lactose on   N  -glycans in the Golgi. In mice lacking ST6GalI, 
the absence of ligands for CD22 might have been expected to 
result in enhanced BCR signaling. Instead, these mice exhibit 
a gross defect in B cell signaling after ligation of the BCR and 
of other mitogenic receptors in B cells (  37  ). One interpreta-
tion provided for these data is that in the absence of     2  –  6-
linked sialic acid in the   ST6GalI  -null mouse, CD22 fails to 
multimerize and cannot be sequestered from the BCR (  50  ). 
It is possible that in the absence of ST6GalI, inhibition of the 
BCR by CD22 is enhanced because of an abnormal facilita-
tion of CD22 and IgM colocalization (  23  ). However, the ba-
sis for this enhanced colocalization is not known, the reason 
for the relatively broad defect in signaling in   ST6GalI   mutant 
mice is not entirely clear, and is it not fully understood why 
these mice have defects in thymocyte development (  38  ). 
  Mice that lack both CD22 and ST6GalI exhibit enhanced 
BCR signaling similar to that seen in CD22-null mice (  23, 51  ). 
Although these data have been interpreted to indicate a res-
toration in the absence of CD22 of BCR signaling that was 
diminished in the absence of ST6Gal I, both studies on 
  cd22      /     /ST6GalI      /        mice do not actually show a restoration 
of BCR signaling to WT levels but demonstrate that BCR 
signaling is enhanced in double mutant mice to levels similar 
to those seen in   cd22      /        B cells. The loss of CD22 may be 
considered to be dominant. These data are therefore compat-
ible with the possibility that CD22 can provide inhibitory 
signals constitutively, presumably by providing ITIM tyro-
sines as a potential substrate for phosphorylation by Lyn and 
other Src family kinases. Nevertheless, CD22 might provide 
optimal inhibitory signals only in the presence of its sialogly-
coconjugate ligands. The total absence of     2  –  6-linked sialic 
acid may represent a relatively drastic alteration that could 
result in aberrant capping of   N  -acetyllactosamine termini of 
many glycans (  52  ) and might aff  ect B cell function adversely 
in poorly understood ways. A subtle alteration of the struc-
ture of CD22 ligands, such as enhanced 9-  O  -acetylation of 
sialic acid in mice with mutant   Siae  , or the combined loss of 
Neu5Gc and enhanced 9-  O  -acetylation of sialic acid in the 
  Cmah  -null mouse and the   Cmah-Siae   double mutant mouse 
both appear to provide somewhat diff  erent insights compared 
with those obtained from the   ST6Gal1   KO mouse harboring 
a more global alteration in CD22 ligand structure. 
  In contrast to   Siae   mutant mice that have detectable anti-
DNA antibodies when they are 5 mo of age,   cd22        /      mice, 
also on a C57BL/6 background, develop anti-DNA antibodies 
only when they are at least 9 mo old, and these latter mice do 
not develop kidney deposits of antibody and complement (  45  ). 
Collectively, the spontaneous secretion of increased levels of 
class switched immunoglobulins and antichromatin antibodies, 
the accumulation of glomerular immune complex deposits, 
and the apparent activation-dependent attrition of follicular 
B cells in   Siae   mutant mice suggest a stronger phenotype in 
these mice than that observed in mice lacking CD22. These 
data suggest indirectly that Siae might not only attenuate CD22 
function but may also possibly regulate an additional Siglec or 
Siglecs in B cells, although direct evidence for such a hypothe-
sis is lacking. A second inhibitory Siglec in murine B cells, Si-
glec G, has been previously described (  53  ). However, although 
Siglec G  –  defi  cient mice exhibit a marked increase in B-1a 
B cells, IgG autoantibodies are not increased. It remains to be 
determined whether this or any other Siglec, other than CD22, 
is regulated by Siae. It also remains to be determined if an en-
gineered defect in   Cmah   leads to an autoimmune state. 
  It has been previously suggested that CD22, Lyn, and 
SHP-1 set a threshold for B cell activation (  46  ). The enhanced JEM VOL. 206, January 19, 2009 
ARTICLE
135
association of rare loss-of-function variants of   SIAE   with au-
toimmune disease, suggesting that the regulatory function of 
Siae is not restricted to rodents (unpublished data). 
    Siae   was identifi  ed over a decade ago as a gene that is regu-
lated during B cell development (  26  ). We have now shown that 
this enzyme regulates the cell surface acetylation of sialic acid. It 
remains to be determined where exactly in B cells Siae is located 
and whether the expression and catalytic activity of this enzyme 
is regulated during antigen-mediated B cell activation. 
  MATERIALS AND METHODS 
  Mice.     8  –  12-wk-old C57BL/6 and B6.129S7-  Rag1   mice (The Jackson Lab-
oratory) were used in this study. Animal procedures were approved by the 
subcommittees on research animal care at Massachussetts General Hospital 
and at the University of California, San Diego. 
  Generation of homozygous   Siae        2/    2   mice.     Exon 2 of   Siae   encoding the 
N terminus of the Lse form of Siae was deleted. The Siae targeting vector 
was assembled from a 129/Sv genomic clone by inserting the 0.7-kb BamHI  –
  XbaI fragment, containing exon 2 of Siae, into the BamHI site of the pfl  ox 
vector (  56  ). Adjacent 129/Sv Siae genomic sequences were added by sub-
cloning the 1.5-kb XbaI  –  NheI fragment into the XhoI site and the BamHI  –
  BamHI 9-kb fragment into the SalI site of pfl  ox. 10   μ  g of NotI-linearized 
targeting vector was electroporated into 150   μ  g/ml R1 ES cells and G418-
resistant transfectants, which was positive by PCR for homologous recombi-
nation and retaining all three loxP sites, and was transfected with the 
pCreHygro expression vector. After 4 d of 2-  μ  M gancyclovir selection, sub-
clones were isolated and those harboring the   Siae  -fl  oxed allele were detected 
by Southern blotting with BamHI  –  SpeI genomic digestion and a loxP probe. 
Two ES cell clones were used to generate chimeric mice in C57BL/6 host 
embryos. Off  spring were genotyped by Southern blotting with BamHI  –  SpeI 
tail DNA hybridized to the 3     probe (3S0.6). Heterozygous off  spring were 
mated to C57BL/6 ZP3-Cre mice. Female off  spring were then mated to 
produce homozygous   Siae        2/    2   mice. PCR primers used for genotyping were 
as follows: PS-LseG-16, 5    -TTTAGGAGCAAGGGGTTGGCCAAGA-3    ; 
PS-LseG-B, 5    -GGTTTCCTGACCTTGGCACAAGGT-3    ; and LOX-R, 
5    -CGGTACCCGGGGATCAATTCGAG-3    . PS-LseG-16 and PS-LseG-
B yield the 420-bp WT band and PS-LseG-16 and LOX-R the 340-bp mu-
tant band. The mice used in these studies were backcrossed into the C57BL/6 
background for 10 generations and then maintained by intercrossing. 
  Antibodies, staining, and fl  ow cytometry.    The following murine mono-
clonal antibody conjugates were used: Allophycocyanin (APC)-RA3-6B2 
(anti-CD45R/B220, rat IgG  2a  ,     ), FITC-S7 (anti-CD43, rat IgG  2a  ,     ), 
FITC-7G6 (anti-CD21/CD35, rat IgG  2b  ), FITC-Cy34.1 (anti-CD22.2, 
mouse [DBA/1] IgG  1  ,     ), APC-53-7.3 (anti-CD5, rat IgG  2a  ,     ), APC-
M1/70 (anti-CD11b, rat IgG  2b  ,     ), r-phycoerythrin (R-PE)-GK1.5 (anti-
CD4, rat IgG  2b  ,     ), and FITC-53-6.7 (anti-CD8a, rat IgG  2a  ,    ; all from BD); 
and APC and R-PE-1B4B1 (anti-IgM, rat IgG), and R-PE-11-26 (anti-
IgD, rat IgG  2a  ,     ; SouthernBiotech). 
  Single cell suspensions were made from spleen, BM (one femur and 
tibia), thymus, and peritoneal washings using standard methodology. Red 
cells were lysed with 2 ml ACK lysing buff  er (Cambrex). The lysis buff  er 
was neutralized by adding 10 ml PBS and 0.2% BSA (PBA). Before staining, 
1   ×   10  6   cells were reacted with 2.5   μ  g of 2.4G2 (anti-CD16/CD32 [Fc     
III/II receptor], rat IgG  2b  ,     ; BD). Surface staining was performed using ap-
propriate dilutions of antibodies in 12   ×   75-mm round-bottom polystyrene 
tubes in a volume of 200   μ  l for 30 min in the dark at 4  °  C. 
  Flow cytometric analysis was performed as previously described (  57  ) on 
a dual laser FC500 (Beckman Coulter), a MoFlo (Dako), and a FACSAria 
(BD). Unstained cells were used to set voltage and single color positive con-
trols were used for electronic compensation. Viable cells were determined by 
forward and side scatter characteristics and 3  –  5   ×   10  4   gated events were col-
lected. Gates were set as previously described (  33  ). Processed samples were 
BCR signaling noted in mice that lack CD22 and in   Siae   mu-
tant mice suggests that loss of tolerance may result from a 
mechanism that is distinct from models invoking clonal dele-
tion, receptor editing, and anergy, all of which might be pre-
sumed to be enhanced, not abrogated, by an increase in BCR 
signal strength in B cells. These well established mechanisms 
of tolerance have been studied extensively using transgenic 
and knockin models that use relatively high-affi   nity BCRs for 
model self-antigens. The analysis of anti  –  HEL-soluble HEL 
double transgenic mice in a   cd22  -null background did not re-
sult in a break in tolerance to HEL (  46, 54  ). We expand here 
on a suggestion originally made by Neuberger and coworkers 
(  45  ) and also discussed by Cornall et al. (  46  ) that CD22, and 
possibly other Siglecs, might set thresholds for the activation 
of B cells in the periphery. Weakly self-reactive B cells may 
not be activated by self-antigens because CD22 helps set an 
activation threshold in the periphery. If the strength of activa-
tion of B cells by self-antigens were to cross a threshold, the 
processing and presentation of self-antigens could be facili-
tated, and the unwanted entry of relatively weakly self-reac-
tive B cells into the germinal center reaction might also occur. 
There are many potential ways in which, during an infection, 
a self-structure may be physically complexed with a foreign 
protein. In a viral infection, for instance, host chromatin may 
contain proteins of viral origin bound to host antigens includ-
ing host nucleic acids. If the BCR threshold signaling is not 
set high enough (because of defects in CD22 or Siae for in-
stance), self-antigens might not only activate weakly self-reac-
tive B cells but may also deliver physically linked foreign 
proteins to endosomes in B cells, thus permitting the receipt 
of T cell help for somatic mutation. It is perhaps signifi  cant 
that in human autoimmune diseases in which antibodies are 
known to be relevant, pathogenic autoantibodies tend to be 
somatically mutated and class switched. Siglecs, assisted by 
Siae, presumably play a key role in keeping weakly self-reac-
tive B cells quiescent. It is clear that analyses of responses to 
one specifi  c T cell  –  dependent synthetic immunogen are not 
apparently consonant with the spontaneous immunoglobulin 
and autoantibody levels observed in   Siae   mutant mice, and 
there is a need for more detailed immunization studies in 
these mutant mice and in controls. 
  Elucidating the full complexity of the biological functions 
of 9-  O  -acetylation of sialic acid will require the analysis of a 
mutant organism that lacks the sialic acid   O  -acetyl transferase 
in the Golgi complex that can transfer an acetyl moiety from 
acetyl CoA to the 7-OH or 9-OH position of terminal sialic 
acid residue on glycoconjugates. Although more than one si-
alic acid   O  -acetyl transferase may exist (  55  ), to date no such 
O-acetyl transferase has been molecularly identifi  ed. Our 
data indicate that modulation of 9-  O  -acetylation of sialic 
acid, a modifi  cation which was fi  rst described more than half 
a century ago (  1  ), regulates inhibitory signaling in B lympho-
cytes and participates in the maintenance of immunological 
tolerance. Furthermore, our ongoing unpublished studies in-
volving deep resequencing of the   SIAE   gene in human con-
trols, and patients with autoimmunity have revealed a strong 136 CELL SURFACE ACETYLATION AND B CELL FUNCTION   | Cariappa et al. 
1% NP40 in PBS. Lysates were immunoprecipitated using anti-CD22 (CD-22 
rabbit IgG; Epitomics, Inc.) and protein A Sepharose, and after separation on 
an SDS/polyacrylamide gel and Western transfer, membranes were probed 
with antibodies to CD22, SHP-1, and phosphotyrosine (anti-CD22.2, clone 
Lyb-8.2 [BD]; anti-SHP1/2 rabbit polyclonal IgG, and antiphosphotyrosine, 
clone 4G10 [Millipore]). Relative expression of CD22 and SHP-1 was quanti-
fi  ed using Quantity One software (Bio-Rad Laboratories). 
  Online supplemental material.     Fig. S1 shows that Siae is secreted from 
stably transfected U2OS cells. Fig. S2 shows that Siae is expressed on the sur-
face of transfected U2OS cells and is also partially present in lysosomes. Fig. S3 
shows the presence of truncated   Siae   mRNA in mutant mice as revealed by 
RT-PCR. Fig. S4 shows accelerated and enhanced BCR-induced calcium 
release in purifi  ed B lymphocytes from   Siae   mutant mice. Figs. S5 and S6 
show that surface expression of CD22 on splenocytes in   Siae        2/    2   mice is un-
altered compared with WT mice. Fig. S7 shows that Siae mutant splenocytes 
proliferate more than WT B cells. Fig. S8 shows a stimulus strength  –  dependent 
inhibition of B cell proliferation after BCR cross-linking. In Fig. S9, 
mutant resting B splenocytes show a mild increase in apoptosis. In Fig. S10, 
peripheral B cell populations and the response to BCR cross-linking of the 
  Cmah  -null mouse are depicted, and in Fig. S11, similar studies are presented 
that were performed on   Siae/Cmah   double mutant mice. Fig. S12 shows 
antibody responses to synthetic T cell  –  dependent and T cell  –  independent 
antigens in   Siae   mutant and WT mice. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20081399/DC1. 
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analyzed using RXP (Beckman Coulter), and FloJo v8.8 (Tree Star, Inc.) 
analysis software. 
  Reconstitution of the lymphoid compartment in Rag-1  –  defi  cient 
mice.       Rag-1      /        mice were irradiated with 7.5 Gy and reconstituted with 
5   ×   10  6   WT or mutant adult BM cells via tail vein injection. Reconstitution 
of the BM and spleen was assessed 7 wk later by fl  ow cytometry. 
  Detection of 9-  O  -acetylated sialic acid on splenocytes.     The CHE-FcD 
probe, a fusion protein composed of the extracellular domains of the infl  u-
enza C hemagglutinin esterase (CHE) which binds 9-  O  -acetylated sialic 
acids, and the Fc portion of human IgG  1  (Fc), treated with diisopropylfl  uo-
rophosphate (D) was generated as previously described (  28, 58  ). The chime-
ric CHE Fc-D protein was precomplexed with Cy5 or FITC-F(ab    )  2   goat 
anti  –  human IgG (Jackson ImmunoResearch Laboratories; 1   μ  l of a 1:10 di-
lution of CHE-FcD in PBA with 2   μ  l of the secondary antibody in a total 
volume of 50   μ  l PBA) for 2 h at 4  °  C in the dark. 10    6    cells in 50   μ  l PBA were 
preincubated for 45 min at 37  °  C, added to the precomplex, and incubated 
on ice for an additional 1.5 h. The cells were washed once, reacted with 
2.4G2, an Fc     III/II receptor-blocking antibody, and surface stained as de-
scribed earlier. Staining of acetylated sialic acid on CD4  +   T cells served as a 
positive control (  28  ). 
  BCR cross-linking and accumulation of cytosolic calcium.     In brief, 
Indo-1 AM (acetoxymethyl ester; Invitrogen) was added to 3   ×   10  6   spleno-
cytes in 500   μ  l HBSS (Invitrogen) and 10% FCS (HBSS-10). The fi  nal con-
centration of Indo-1 was 1   μ  M. The cells were incubated in a 37  °  C water bath 
for 30 min, held at room temperature for 5 min, and washed with HBSS con-
taining 2 mM Hepes buff  er and no serum (HBSH-0). All manipulations in-
cluding the incubation were in the dark. Cells were then reacted with 2.4G2, 
an Fc     III/II receptor-blocking antibody, surface stained as described earlier, 
and washed with HBSH-0, all in the dark at 4  °  C. The cells were resuspended 
in the residual volume and an additional 50   μ  l HBSH-0 was added to make a 
total volume of     150   μ  l. The cells were then split into three 50-  μ  l aliquots and 
the volume made up to 100   μ  l with HBSH-0. The cells were held in the dark 
at 4  °  C before analysis. Before calcium fl  ux measurements, the cells were fi  l-
tered and incubated at RT for 10 min. The cells were warmed to 37  °  C in a 
heat block for 6 min and placed in the fl  ow cytometer in a chamber main-
tained at 37  °  C. After a fl  ow rate of     500 cells/s was established, acquisition 
was begun to record a 30-s baseline. After addition of stimulatory antibody 
(Fab  2   fragments of anti-IgM), acquisition was continued for another 180 s with 
the cells at 37  °  C. Between samples, distilled water was run at a high fl  ow rate 
for 2 min to fl  ush the lines. The fl  ow cytometer used was a FACS Vantage SE 
(BD) operating with a laser (Innova Enterprise Model 621; Coherent, Inc.). 
  Serum immunoglobulins and autoantibodies.     Total serum immuno-
globulins of various isotypes were analyzed using an ELISA approach (Alpha 
Diagnostic International, San Antonio, TX). ELISA was also used to quan-
tify serum autoantibodies (anti-dsDNA, anti-ssDNA, anti-histone, anti-Sm) 
and circulating immune complexes (all from Alpha Diagnostic). 
  Immunofl   uorescence staining, immunohistochemistry and histo-
logical staining.     Immunofl  uorescence was performed as previously de-
scribed (  59  ) with some modifi   cations. Sections for immunofl  uorescence 
were blocked with 20% normal goat serum in 1% BSA/PBS for 20 min and 
stained with FITC-Affi   niPure F(ab    )  2   goat anti  –  mouse IgG (H + L; Jackson 
ImmunoResearch Laboratories) diluted 1:200 in 5% normal goat serum/1% 
BSA/PBS for 15 min in the dark at room temperature. After rinsing three 
times in PBS for 5     each, sections were mounted using 25   μ  l of Vectashield 
(Vector Laboratories). Immunohistochemistry was performed as described 
previously (  60  ). Paraffi   n sections were stained with hematoxylin and eosin 
and the periodic acid Schiff   reagent using standard methods. 
  Immunoprecipitation and Western blot analysis.     The method used by 
Poe et al. (  22  ) was adhered to with some modifi  cations. 10  7   murine spleno-
cytes or sorted 5   ×   10  5   B cells were lysed before and after BCR ligation using JEM VOL. 206, January 19, 2009 
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